Negative d-Dimer Result To Exclude Recurrent Deep Venous Thrombosis: A Management Trial

Por Rathbun, Suman W., Whitsett, Thomas L., Raskob, Gary E.
Publicado em 2004

Injury Prevention And Control Research And Training In Accredited Schools Of Public Health: A CDC/ASPH Assessment

Por Hemenway, David, Aglipay, Geraldine S, Helsing, Karen L, Raskob, Gary E
Publicado em 2006

Clinical Utility of D-dimer in Patients With Suspected Pulmonary Embolism and Nondiagnostic Lung Scans or Negative CT Findings

Por Rathbun, Suman W., Whitsett, Thomas L., Vesely, Sara K., Raskob, Gary E.
Publicado em 2004

The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs

Por Grosse, Scott D., Nelson, Richard E., Nyarko, Kwame A., Richardson, Lisa C., Raskob, Gary E.
Publicado no Thromb Res (2015)

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Por Büller, Harry R., Bethune, Claudette, Bhanot, Sanjay, Gailani, David, Monia, Brett P., Raskob, Gary E., Segers, Annelise, Verhamme, Peter, Weitz, Jeffrey I.
Publicado no N Engl J Med (2014)

Clinical features of paediatric pulmonary hypertension: a registry study

Por Berger, Rolf M F, Beghetti, Maurice, Humpl, Tilman, Raskob, Gary E, Ivy, D Dunbar, Jing, Zhi-Cheng, Bonnet, Damien, Schulze-Neick, Ingram, Barst, Robyn J
Publicado em 2012

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Por Prins, Martin H, Lensing, Anthonie WA, Bauersachs, Rupert, van Bellen, Bonno, Bounameaux, Henri, Brighton, Timothy A, Cohen, Alexander T, Davidson, Bruce L, Decousus, Hervé, Raskob, Gary E, Berkowitz, Scott D, Wells, Philip S
Publicado em 2013